Are CMV and SARS-CoV-2 Infections Mutual Risk Factors in Kidney Transplant Recipients?
Throughout the years, much progress has been made in the field of renal transplantation; however, along with new developments, new problems have arisen. While transplantation is the optimal choice in patients suffering from end-stage renal disease, it is always connected to certain commonly associat...
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2022-03-01
|
| Series: | Transplantology |
| Subjects: | |
| Online Access: | https://www.mdpi.com/2673-3943/3/1/10 |
| _version_ | 1797441275738193920 |
|---|---|
| author | Julia Swist Mateusz Krotofil Oktawia Mazanowska Magdalena Krajewska Dorota Kamińska |
| author_facet | Julia Swist Mateusz Krotofil Oktawia Mazanowska Magdalena Krajewska Dorota Kamińska |
| author_sort | Julia Swist |
| collection | DOAJ |
| description | Throughout the years, much progress has been made in the field of renal transplantation; however, along with new developments, new problems have arisen. While transplantation is the optimal choice in patients suffering from end-stage renal disease, it is always connected to certain commonly associated risks, in particular those caused by opportunistic infections. One such risk includes the reactivation of cytomegalovirus (CMV), an issue commonly affecting all kinds of transplant recipients. Similarly, with the rise of the ever-evolving global SARS-CoV-2 pandemic, patients must be constantly monitored for any respiratory symptoms, and observed closely under the care of their attending physician. Treating these patients has become extremely difficult due to limitations caused by COVID-19 protocols (for instance, the reduction of immunosuppression dosages and the avoidance of lymphocyte-depleting induction therapy) and the lack of knowledge surrounding this relatively new and worsening risk factor. In order to give patients optimal care, these arising problems need to be studied and addressed. |
| first_indexed | 2024-03-09T12:21:40Z |
| format | Article |
| id | doaj.art-44e70be0b9ee4adc969d373ba8e15318 |
| institution | Directory Open Access Journal |
| issn | 2673-3943 |
| language | English |
| last_indexed | 2024-03-09T12:21:40Z |
| publishDate | 2022-03-01 |
| publisher | MDPI AG |
| record_format | Article |
| series | Transplantology |
| spelling | doaj.art-44e70be0b9ee4adc969d373ba8e153182023-11-30T22:39:58ZengMDPI AGTransplantology2673-39432022-03-013110310810.3390/transplantology3010010Are CMV and SARS-CoV-2 Infections Mutual Risk Factors in Kidney Transplant Recipients?Julia Swist0Mateusz Krotofil1Oktawia Mazanowska2Magdalena Krajewska3Dorota Kamińska4Faculty of Medicine, Wroclaw Medical University, 50-556 Wroclaw, PolandFaculty of Medicine, Wroclaw Medical University, 50-556 Wroclaw, PolandDepartment of Nephrology and Transplantation Medicine, Wroclaw Medical University, 50-556 Wroclaw, PolandDepartment of Nephrology and Transplantation Medicine, Wroclaw Medical University, 50-556 Wroclaw, PolandDepartment of Nephrology and Transplantation Medicine, Wroclaw Medical University, 50-556 Wroclaw, PolandThroughout the years, much progress has been made in the field of renal transplantation; however, along with new developments, new problems have arisen. While transplantation is the optimal choice in patients suffering from end-stage renal disease, it is always connected to certain commonly associated risks, in particular those caused by opportunistic infections. One such risk includes the reactivation of cytomegalovirus (CMV), an issue commonly affecting all kinds of transplant recipients. Similarly, with the rise of the ever-evolving global SARS-CoV-2 pandemic, patients must be constantly monitored for any respiratory symptoms, and observed closely under the care of their attending physician. Treating these patients has become extremely difficult due to limitations caused by COVID-19 protocols (for instance, the reduction of immunosuppression dosages and the avoidance of lymphocyte-depleting induction therapy) and the lack of knowledge surrounding this relatively new and worsening risk factor. In order to give patients optimal care, these arising problems need to be studied and addressed.https://www.mdpi.com/2673-3943/3/1/10COVID-19kidney transplantationcytomegalovirus |
| spellingShingle | Julia Swist Mateusz Krotofil Oktawia Mazanowska Magdalena Krajewska Dorota Kamińska Are CMV and SARS-CoV-2 Infections Mutual Risk Factors in Kidney Transplant Recipients? Transplantology COVID-19 kidney transplantation cytomegalovirus |
| title | Are CMV and SARS-CoV-2 Infections Mutual Risk Factors in Kidney Transplant Recipients? |
| title_full | Are CMV and SARS-CoV-2 Infections Mutual Risk Factors in Kidney Transplant Recipients? |
| title_fullStr | Are CMV and SARS-CoV-2 Infections Mutual Risk Factors in Kidney Transplant Recipients? |
| title_full_unstemmed | Are CMV and SARS-CoV-2 Infections Mutual Risk Factors in Kidney Transplant Recipients? |
| title_short | Are CMV and SARS-CoV-2 Infections Mutual Risk Factors in Kidney Transplant Recipients? |
| title_sort | are cmv and sars cov 2 infections mutual risk factors in kidney transplant recipients |
| topic | COVID-19 kidney transplantation cytomegalovirus |
| url | https://www.mdpi.com/2673-3943/3/1/10 |
| work_keys_str_mv | AT juliaswist arecmvandsarscov2infectionsmutualriskfactorsinkidneytransplantrecipients AT mateuszkrotofil arecmvandsarscov2infectionsmutualriskfactorsinkidneytransplantrecipients AT oktawiamazanowska arecmvandsarscov2infectionsmutualriskfactorsinkidneytransplantrecipients AT magdalenakrajewska arecmvandsarscov2infectionsmutualriskfactorsinkidneytransplantrecipients AT dorotakaminska arecmvandsarscov2infectionsmutualriskfactorsinkidneytransplantrecipients |